As shown in the results above, Ang II can promote the expression of p-ERK, p-STAT3, and NFAT2, while Farrerol and ERK inhibitors can significantly inhibit their expression, and we found that Farrerol may exert an anti-cardiac hypertrophy effect through MAPK/ERK. This evidence concerns the gene STAT3 and cardiac hypertrophy.